FDA
Evidence lacking for widespread use of costly antipsychotic drugs, says Stanford researcher
STANFORD, Calif. — Many prescriptions for the top-selling class of drugs, known as atypical antipsychotic medications, lack strong evidence that the drugs will actually help, a study by researchers at the Stanford University School of Medicine an…
Promising treatment for metastatic melanoma ‘fast tracked’ by FDA
HACKENSACK, N.J. (September 9, 2010) — Researchers from the John Theurer Cancer Center at Hackensack University Medical Center played an important role in a study that led to the Food & Drug Administration’s (FDA) recent fast tracking of ipilimum…